DRKS00012862RecruitingNot Applicable
Clinical and Immunological Categorization of Pulmonary Aspergillosis in Cystic Fibrosis
Charite Universitätsmedizin Berlin0 sites200 target enrollmentStarted: September 4, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 6 Years to 70 Years (—)
- Sex
- All
Inclusion Criteria
- •Provide written informed consent
- •- Confirmed diagnosis of CF
- •- Aged between 6 and 70 years
- •- Ability to do a lung function test and to provide sputum samples for microbiological evaluation
Exclusion Criteria
- •Participants will not be entered in the study for any of the following exclusion criteria:
- •- Patients unable to sign informed consent or unwilling to comply with the procedural
- •requirements of this clinical protocol.
- •- No ability to do a lung function test and to provide sputum samples for microbiological evaluation.
- •- Not possible to take blood
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Studying the clinical profile of PAH in infants, including their biochemical and genetic parametersCTRI/2021/06/034160Kasturba Medical College Manipal
Recruiting
Not Applicable
Clinical courses and Prognostic factors for pulmonary fibrosis followed by pneumonia in patient with COVID19 pneumoniaCodes for special purposesKCT0006658ational Medical Center124
Not yet recruiting
Unknown
Clinical Profile and Outcome of Pulmonary Disease in patients admitted in Respiratory Intensive Care UnitCTRI/2024/05/066916Rohilkhand Medical College and Hospital
Recruiting
Not Applicable
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200
Completed
Not Applicable
Prevalence and clinical course of pulmonary manifestations in patients with chronic liver diseaseJPRN-UMIN000043430agoya University150